ZUSAMMENSETZUNGEN ZUR VERWENDUNG BEI DER BEHANDLUNG DER OSTEOPOROSE UND/ODER DER ENTZÜNDLICHEN GELENKERKRANKUNGEN

摘要

Compositions and pharmaceutical compositions are described which comprise: a component A comprising one or more flavonol glycosides, a component B comprising one or more tetrahydrofolic acid compounds, a component C comprising one or more calcium supplements, and a component D comprising one or more magnesium supplements. Methods of using such compositions and pharmaceutical compositions to treat and/or prevent osteoporosis and/or an inflammatory joint disease are also described.